Cargando…
A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis?
BACKGROUND: The incidence of Hodgkin lymphoma (HL) among HIV-infected individuals remains unchanged since the introduction of combination antiretroviral therapy (cART). Recent epidemiological data suggest that CD4 count decline over a year is associated with subsequent diagnosis of HL. In an era of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913599/ https://www.ncbi.nlm.nih.gov/pubmed/24504076 http://dx.doi.org/10.1371/journal.pone.0087442 |
_version_ | 1782302252908675072 |
---|---|
author | Gupta, Ravindra K. Marks, Michael Edwards, Simon G. Smith, Katie Fletcher, Katie Lee, Siow-Ming Ramsay, Alan Copas, Andrew J. Miller, Robert F. |
author_facet | Gupta, Ravindra K. Marks, Michael Edwards, Simon G. Smith, Katie Fletcher, Katie Lee, Siow-Ming Ramsay, Alan Copas, Andrew J. Miller, Robert F. |
author_sort | Gupta, Ravindra K. |
collection | PubMed |
description | BACKGROUND: The incidence of Hodgkin lymphoma (HL) among HIV-infected individuals remains unchanged since the introduction of combination antiretroviral therapy (cART). Recent epidemiological data suggest that CD4 count decline over a year is associated with subsequent diagnosis of HL. In an era of economic austerity monitoring the efficacy of cART by CD4 counts may no longer be required where CD4 count>350 cells/µl and viral load is suppressed (<50 copies/ml). METHODS: We sought to establish among our HIV outpatient cohort whether a CD4 count decline prior to diagnosis of HL, whether any decline was greater than in patients without the diagnosis, and also whether other clinical or biochemical indices were reliably associated with the diagnosis. RESULTS: Twenty-nine patients with a diagnosis of HL were identified. Among 15 individuals on cART with viral load <50 copies/ml the change in CD4 over 12 months preceding diagnosis of HL was −82 cells/µl (95% CI −163 to −3; p = 0.04). Among 18 matched controls the mean change was +5 cells/µl, 95% CI −70 to 80, p = 0.89). The decline in CD4 over the previous 6–12 months was somewhat greater in cases than controls (mean difference in change −55 cells/µl, 95% CI −151 to 39; p = 0.25). In 26 (90%) patients B symptoms had been present for a median of three months (range one–12) before diagnosis of HL. CONCLUSIONS: The CD4 count decline in the 12 months prior to diagnosis of Hodgkin lymphoma among HIV-infected individuals with VL<50 copies/ml on cART was not significantly different from that seen in other fully virologically suppressed individuals in receipt of cART and who did not develop HL. All those who developed HL had B symptoms and/or new palpable lymphadenopathy, suggesting that CD4 count monitoring if performed less frequently, or not at all, among those virologically suppressed individuals with CD4 counts >350 may not have delayed diagnosis. |
format | Online Article Text |
id | pubmed-3913599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39135992014-02-06 A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? Gupta, Ravindra K. Marks, Michael Edwards, Simon G. Smith, Katie Fletcher, Katie Lee, Siow-Ming Ramsay, Alan Copas, Andrew J. Miller, Robert F. PLoS One Research Article BACKGROUND: The incidence of Hodgkin lymphoma (HL) among HIV-infected individuals remains unchanged since the introduction of combination antiretroviral therapy (cART). Recent epidemiological data suggest that CD4 count decline over a year is associated with subsequent diagnosis of HL. In an era of economic austerity monitoring the efficacy of cART by CD4 counts may no longer be required where CD4 count>350 cells/µl and viral load is suppressed (<50 copies/ml). METHODS: We sought to establish among our HIV outpatient cohort whether a CD4 count decline prior to diagnosis of HL, whether any decline was greater than in patients without the diagnosis, and also whether other clinical or biochemical indices were reliably associated with the diagnosis. RESULTS: Twenty-nine patients with a diagnosis of HL were identified. Among 15 individuals on cART with viral load <50 copies/ml the change in CD4 over 12 months preceding diagnosis of HL was −82 cells/µl (95% CI −163 to −3; p = 0.04). Among 18 matched controls the mean change was +5 cells/µl, 95% CI −70 to 80, p = 0.89). The decline in CD4 over the previous 6–12 months was somewhat greater in cases than controls (mean difference in change −55 cells/µl, 95% CI −151 to 39; p = 0.25). In 26 (90%) patients B symptoms had been present for a median of three months (range one–12) before diagnosis of HL. CONCLUSIONS: The CD4 count decline in the 12 months prior to diagnosis of Hodgkin lymphoma among HIV-infected individuals with VL<50 copies/ml on cART was not significantly different from that seen in other fully virologically suppressed individuals in receipt of cART and who did not develop HL. All those who developed HL had B symptoms and/or new palpable lymphadenopathy, suggesting that CD4 count monitoring if performed less frequently, or not at all, among those virologically suppressed individuals with CD4 counts >350 may not have delayed diagnosis. Public Library of Science 2014-02-04 /pmc/articles/PMC3913599/ /pubmed/24504076 http://dx.doi.org/10.1371/journal.pone.0087442 Text en © 2014 Gupta et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gupta, Ravindra K. Marks, Michael Edwards, Simon G. Smith, Katie Fletcher, Katie Lee, Siow-Ming Ramsay, Alan Copas, Andrew J. Miller, Robert F. A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? |
title | A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? |
title_full | A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? |
title_fullStr | A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? |
title_full_unstemmed | A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? |
title_short | A Declining CD4 Count and Diagnosis of HIV-Associated Hodgkin Lymphoma: Do Prior Clinical Symptoms and Laboratory Abnormalities Aid Diagnosis? |
title_sort | declining cd4 count and diagnosis of hiv-associated hodgkin lymphoma: do prior clinical symptoms and laboratory abnormalities aid diagnosis? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913599/ https://www.ncbi.nlm.nih.gov/pubmed/24504076 http://dx.doi.org/10.1371/journal.pone.0087442 |
work_keys_str_mv | AT guptaravindrak adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT marksmichael adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT edwardssimong adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT smithkatie adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT fletcherkatie adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT leesiowming adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT ramsayalan adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT copasandrewj adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT millerrobertf adecliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT guptaravindrak decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT marksmichael decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT edwardssimong decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT smithkatie decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT fletcherkatie decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT leesiowming decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT ramsayalan decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT copasandrewj decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis AT millerrobertf decliningcd4countanddiagnosisofhivassociatedhodgkinlymphomadopriorclinicalsymptomsandlaboratoryabnormalitiesaiddiagnosis |